抗发作药物对的心血管影响
Maromi Nei1, Jeremy Ho2, Reginald T Ho3
1Department of Neurology, Jefferson Comprehensive Epilepsy Center, Sidney Kimmel Medical College at Thomas Jefferson University, 901 Walnut Street, Suite 400, Philadelphia, PA, 19107, USA. maromi.nei@jefferson.edu.
治疗的抗发作药物 (ASM) 可以通过影响脂质和离子通道增加心脏风险. 仔细监测和管理至关重要,以减轻患者的这些心血管影响.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 的治疗主要依赖于抗发作药物 (ASM).
- ASM可能会造成心血管不良事件的风险,包括缺血性心脏病和心律不整.
- 这些风险与ASM对脂质代谢和心脏离子通道的影响有关.
研究的目的:
- 审查ASMs对心血管的影响的文献.
- 为了识别具有较高心血管风险概况的ASM.
- 为神经病学和心脏病学提供实用的管理和监测建议.
主要方法:
- 叙事文学评论. 叙事文学评论. 叙事文学评论. 叙事文学评论.
- 分析ASM对脂质代谢和心脏离子通道的影响.
- 检查有关中心脏事件的人口数据.
主要成果:
- 某些ASM,特别是高剂量/持续时间的酶诱导剂,可以对脂质产生负面影响,增加缺血性心脏病风险.
- 许多ASM阻断通道或影响QT间隔,可能导致前节律失常,特别是在多药或易受伤害的患者.
- 人口数据表明中心律不整和心脏突然死亡增加,可能被低估并与ASM相关.
结论:
- 通过代谢和前节律影响,ASM有助于的心血管发病率和死亡率.
- 阻断道的ASMs可能特别涉及心律失常和心脏突然死亡.
- 解决心血管风险因素和优化ASM管理对于患者护理至关重要.
更多相关视频
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
11:54Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
Published on: January 29, 2018
相关概念视频
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
